Ohcanbohtosat - Limor Rubin
Čálihuva vuohččan sisa
- Čájehuvvo 1 - 10 / 10
-
1
Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity Dahkki Lijun Ge, Shuyuan Liu, Limor Rubin, Philip Lazarovici, Wenhua Zheng
Almmustuhtton 2022-02-01
Artihkal -
2
Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center Experience Dahkki Yuval Ishay, Ariel Kenig, Limor Rubin, Oded Shamriz, Fadi Kharouf
Almmustuhtton 2022-01-01
Artihkal -
3
Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds Dahkki Yaarit Ribak, Limor Rubin, Aviv Talmon, Zvi Dranitzki, Oded Shamriz, Isca Hershkowitz, Yuval Tal, Alon Y. Hershko
Almmustuhtton 2023-08-01
Artihkal -
4
Rasagiline Exerts Neuroprotection towards Oxygen–Glucose-Deprivation/Reoxygenation-Induced GAPDH-Mediated Cell Death by Activating Akt/Nrf2 Signaling Dahkki Shimon Lecht, Adi Lahiani, Michal Klazas, Majdi Saleem Naamneh, Limor Rubin, Jiayi Dong, Wenhua Zheng, Philip Lazarovici
Almmustuhtton 2024-07-01
Artihkal -
5
Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events Dahkki Michal Lotem, Limor Rubin, Aviv Talmon, Yaarit Ribak, David Lavie, Hovav Nechushtan, Nadia Caplan, Oded Shamriz, Irit Adini, Yuval Tal
Almmustuhtton 2024-10-01
Artihkal -
6
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome Dahkki Limor Rubin, Aviv Talmon, Yaarit Ribak, Asa Kessler, Yossi Martin, Tal Keidar Haran, Oded Shamriz, Oded Shamriz, Irit Adini, Yuval Tal
Almmustuhtton 2023-04-01
Artihkal -
7
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis Dahkki Chaim Gilon, Michal Klazas, Adi Lahiani, Adi Schumacher-Klinger, Shira Merzbach, Johnny N. Naoum, Haim Ovadia, Limor Rubin, Susan Cornell-Kennon, Erik M. Schaefer, Jehoshua Katzhendler, Cezary Marcinkiewicz, Amnon Hoffman, Philip Lazarovici
Almmustuhtton 2021-11-01
Artihkal -
8
Dupilumab for cancer-associated refractory pruritus Dahkki Aviv Talmon, MD, Shlomo Elias, MD, PhD, Limor Rubin, MD, Yaarit Ribak, MD, Eyal Ben Dori, MD, Oded Shamriz, MD, Michal Lotem, MD, Irit Adini, PhD, Yuval Tal, MD, PhD
Almmustuhtton 2023-08-01
Artihkal -
9
Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience Dahkki Oded Shamriz, Oded Shamriz, Limor Rubin, Amos J. Simon, Amos J. Simon, Atar Lev, Ortal Barel, Ortal Barel, Raz Somech, Maya Korem, Sigal Matza Porges, Sigal Matza Porges, Tal Freund, David Hagin, Ben Zion Garty, Ben Zion Garty, Ben Zion Garty, Amit Nahum, Vered Molho Pessach, Yuval Tal
Almmustuhtton 2022-12-01
Artihkal -
10
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vacc... Dahkki Fadi Kharouf, Fadi Kharouf, Tali Eviatar, Tali Eviatar, Maya Braun, Elisheva Pokroy-Shapira, Elisheva Pokroy-Shapira, Michal Brodavka, Michal Brodavka, Yair Zloof, Nancy Agmon-Levin, Nancy Agmon-Levin, Kochava Toledano, Kochava Toledano, Shirly Oren, Shirly Oren, Merav Lidar, Merav Lidar, Devy Zisman, Devy Zisman, Yonit Tavor, Yonit Tavor, Mirit Amit-Vazina, Mirit Amit-Vazina, Firas Sabbah, Gabriel S. Breuer, Gabriel S. Breuer, Amir Dagan, Amir Dagan, Rima Beshara-Garzuzi, Rima Beshara-Garzuzi, Doron Markovits, Doron Markovits, Muna Elias, Muna Elias, Joy Feld, Joy Feld, Oshrat Tayer-Shifman, Oshrat Tayer-Shifman, Tal Gazitt, Tal Gazitt, Tatiana Reitblatt, Limor Rubin, Limor Rubin, Amir Haddad, Amir Haddad, Sami Giryes, Sami Giryes, Daphna Paran, Daphna Paran, Hagit Peleg, Hagit Peleg, Yair Molad, Yair Molad, Ori Elkayam, Ori Elkayam, Dror Mevorach, Dror Mevorach, Alexandra Balbir-Gurman, Alexandra Balbir-Gurman, Yolanda Braun-Moscovici, Yolanda Braun-Moscovici
Almmustuhtton 2023-03-01
Artihkal